Literature DB >> 8578505

Progress towards gene therapy for the hemophilias.

A R Thompson1.   

Abstract

A variety of vector systems and approaches for transferring the genes for factors VIII and IX are being investigated. This indicates that there is no clearly superior technique that has emerged. However, considerable progress is being made in factor expression in animal models. In addition, as mechanisms of vector biology are elucidated, this facilitates more rational design of vector improvements.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578505

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  2 in total

1.  A factor IX-deficient mouse model for hemophilia B gene therapy.

Authors:  L Wang; M Zoppè; T M Hackeng; J H Griffin; K F Lee; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy.

Authors:  S R Cai; S C Kennedy; W M Bowling; M W Flye; K P Ponder
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.